Blow fill seal (BFS) technology is highly sought-after as a preferred packaging solution in pharmaceutical manufacturing. It utilizes a single integrated machine to produce formulated drugs aseptically without any human intervention. According to Future Market Insights (FMI), the BFS technology market is set to reach US$ 2.6 Bn by the end of 2021. Overall growth forecast remains positive for the market, especially as demand for effective packaging technology continues to rise across various industries.
By using BFS technology, the plastic is blown, filled with the formulated product and sealed inside the machine continuously without any kind of external contamination. It is a fast, precise, and safe method for pharmaceutical filling and it uses lesser energy. The material used is often recyclable and more durable than glass. The machine is capable of producing different shapes according to the end user’s requirements. As BFS technology increases processing speed and supports contamination free packaging, this technology becomes a first choice of many end users.
Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-4407
The BFS technology finds application across diverse industries. However, pharmaceutical industry remains its key end user. Main products produced using this technology are the bottles, ampoules, vials and pre-filled syringes, etc. which are used in filling of medicines, vaccines, ophthalmic, respiratory, injectable drugs, wound care, and biologics. Apart from this, BFS technology has applications in food & beverage, cosmetic and personal care, and many other industries.
Key Takeaways of Blow Fill Seal Technology Market Study
- The BFS technology market is to exhibit 5.4% Y-o-Y growth in 2021
- The U.S. will emerge as a highly lucrative destination, accounting for over 84% of the North America market
- The U.K. is set to exhibit 8% Y-o-Y growth in 2021
- France and Germany will emerge as highly lucrative markets for BFS technology in Europe
- Japan and South Korea will continue exhibiting high demand
“Blow fill seal technology has been witnessing high demand from pharmaceutical companies in Latin America and Asia Pacific. Unit dosage packaging, such as prefilled syringes are in high demand, which in turn is spurring the demand for blow fill seal technology in these regions” says an FMI analyst.
Blow Fill Seal Technology Aids in Curbing Medical Non Adherence Issues
Over the past two decades, medical adherence has created a very critical situation for healthcare & pharmaceutical industry.
- For instance: in USA, according to FMI study, it has been noticed that ~40%-50% of prescribed medications are not taken by the patients appropriately. Along with this, according to a study conducted by the Intercontinental Medical Statistics (IMS) health, it has been noticed that the matter of not taking medicine appropriately at right time is costing patients more than $200 Bn.
To contain the issue, the pharmaceutical industry is continually making efforts for improving medication packaging. The industry is focusing on appropriate and easy packaging for ensuring the matter of “right dose at right time”.
Against this backdrop, the demand for technologies that can instruct the patients to take accurate dose in a timely manner is rising. Companies, especially in North America are adopting blow fill seal technology to help to ensure better drug intake in a single dose.
Blow Fill Seal Technology Market by Category
By Product Type
- Bottles
- 0.2-100 ml
- 100-500 ml
- Above 500 ml
- Ampules
- 0.1-10 ml
- 10-100 ml
- Vials
- 0.1-10 ml
- 10-50 ml
- Others(prefilled syringes & Injectables)
By Material Type
- PE
- LDPE
- HDPE
- PP
- Others
By End Use
- Pharmaceuticals
- Ophthalmic
- Injectables
- Food & Beverage
- Cosmetics & Personal Care
- Others
Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-4407
Blow Fill Seal Technology Market Landscape
Unither Pharmaceuticals SAS, Catalent, Inc., Curida AS, Unipharma LLC, Weiler Engineering Inc, GlaxoSmithKline plc, Takeda Pharmaceuticals International AG, Nephron Pharmaceuticals Corporation, Horizon Pharmaceutical Inc, Brevetti Angela S.R.L, Recipharm AB, Laboratorios SALVAT, S.A, The Ritedose Corporation, Unicep Packaging, LLC, Pharmapack Co. Ltd, Amanta Healthcare Ltd., Automatic Liquid Packaging Solutions LLC, Asept Pak, Inc and SIFI Spa are some of the keyplayers in the blow fill seal technology market. The blow fill seal technology market is fragmented and the Tier 1 players in the market hold 40-45% share in the global blow fill seal technology market.
Blow Fill Seal Technology Market Report
Future Market Insights, in its new report, offers an unbiased analysis of the global blow fill seal technology market, analysing historical demand from 2016-2020 and forecast statistics for 2021-2031. The study reveals growth projections on the blow fill seal technology market on the basis of product type (bottles (0.2-100 ml, 100-500ml, and above 500ml), ampules (0.1-10 ml and 10-100 ml), vials (0.1-10 ml and 10-50 ml), and others (prefilled syringes & injectables)), material type (PE, (LDPE and HDPE), PP, and others), end use (pharmaceuticals (ophthalmic, injectable, biologics, wound care and respiratory), food & beverage, cosmetics & personal care, and others across seven regions.
